Of course, they cite Ariad as having spent $444M to create "1" new drug -- I'll assume this is Iclusig.
What this analysis leaves out is the parade of indications, which is to say that calling Iclusig "one drug" in the way DNDN's drug was "one drug" is a bit of a misnomer.